RIGL Rigel Pharmaceuticals, Inc. - Common Stock
NASDAQ · Biotechnology · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Ago 4, 2026
$47,15
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$24,95minimo 52 sett.
$52,24massimo 52 sett.
Capitalizzazione di Mercato
$863M
P/E (TTM)
2.8
EPS (TTM)
$16.89
Ricavi (TTM)
$277M
i tuoi badge
Intervallo 52 sett.
$25–$52
Rating Analisti
STRONG BUY
Prezzo Obiettivo
$63
P/E
2.8
ROE
126.9%
Margine di Profitto Netto
116.3%
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
RIGL Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$47.15
Capitalizzazione di Mercato
$863M
P/E (TTM)
2.8
EPS (TTM)
$16.89
Ricavi (TTM)
$277M
ROE (TTM)
126.9%
Intervallo 52 sett.
$25–$52
RIGL Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Split azionari
| Data ex-dividendo | Split | Tipo |
|---|---|---|
| 27 Giugno 2024 | 1-for-10 | Inverso |
| 25 Giugno 2003 | 1-for-9 | Inverso |
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi$294M2016-12-31 → 2025-12-31
EPS$19.482019-12-31 → 2025-12-31
Flusso di cassa libero·2016-12-31 → 2022-12-31
Margine netto116.3%2018-12-31 → 2025-12-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | RIGL | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E (TTM) | 2.8media 5 anni ≈-47.2 | ≈-47.2 | · | · | |
| P/S | 2.9media 5 anni ≈15.6 | ≈15.6 | 12.6 | Sottovalutato | |
| P/B | 2.2media 5 anni ≈-7.4 | ≈-7.4 | 4.6 | Sottovalutato | |
| Price / Cash Flow (Prezzo / Flusso di cassa) | 11.4media 5 anni ≈63.4 | ≈63.4 | · | · | |
| Price / Tangible Book (Prezzo / Valore contabile tangibile) | 2.4 | · | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | RIGL | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Margine Operativo (TTM) | 31.5%media 5 anni ≈-3.2% | ≈-3.2% | -180.0% | Di prim'ordine | |
| Margine EBITDA (TTM) | 32.4%media 5 anni ≈-2.2% | ≈-2.2% | -180.0% | Di prim'ordine | |
| Margine ante imposte (TTM) | 30.9%media 5 anni ≈-6.0% | ≈-6.0% | -170.5% | Di prim'ordine | |
| Margine di Profitto Netto (TTM) | 116.3%media 5 anni ≈10.5% | ≈10.5% | -170.6% | Di prim'ordine | |
| ROA (TTM) | 88.5%media 5 anni ≈9.8% | ≈9.8% | -39.1% | Di prim'ordine | |
| ROE (TTM) | 126.9%media 5 anni ≈47.1% | ≈47.1% | -50.7% | Di prim'ordine | |
| ROIC | 96.5%media 5 anni ≈251.5% | ≈251.5% | -59.1% | Di prim'ordine |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | RIGL | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Rapporto corrente (MRQ) | 1.9media 5 anni ≈2.1 | ≈2.1 | 11.7 | Bassa liquidità | |
| Quick Ratio (MRQ) | 1.6media 5 anni ≈1.9 | ≈1.9 | 4.9 | Sotto la media |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
| Metrica | Tendenza 5 anni | RIGL | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Revenue YoY (Ricavi YoY) | 64.1%media 5 anni ≈26.5% | ≈26.5% | · | · | |
| Revenue CAGR 3Y (CAGR Ricavi 3Y) | 34.8%media 5 anni ≈14.5% | ≈14.5% | · | · | |
| Revenue CAGR 5Y (CAGR Ricavi 5Y) | 22.1% | · | · | · | |
| EPS YoY | 1867.7% | · | · | · | |
| Net Income YoY (Utile Netto YoY) | 1999.1% | · | · | · |
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
| Metrica | Tendenza 5 anni | RIGL | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Asset Turnover (Rotazione delle attività) | 0.9media 5 anni ≈1.0 | ≈1.0 | 0.5 | Di prim'ordine | |
| Inventory Turnover (Rotazione delle scorte) | 2.2media 5 anni ≈1.4 | ≈1.4 | · | · | |
| Receivables Turnover (Rotazione dei crediti) | 6.3media 5 anni ≈5.7 | ≈5.7 | · | · | |
| Revenue / Employee (Ricavi / Dipendente) | ≈$1.7M | · | · | · |
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
111.8%
Prossimo report
Nov 02, 2026
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | Ago 3, 2026 | $0.88 | $0.63 | 39.2% |
| 31 Marzo 2026 | $0.44 | $0.78 | -43.2% | |
| 31 Dicembre 2025 | $1.15 | $1.27 | -9.6% | |
| 30 Settembre 2025 | $1.46 | $0.87 | 67.5% | |
| 30 Giugno 2025 | $3.28 | $2.63 | 24.6% | |
| 31 Marzo 2025 | $0.63 | $0.09 | 592.3% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $294M | $179M | $117M | $120M | $149M | $109M | $59M | $45M | $4M | $20M | |
| Cost of Revenue | $20M | $19M | $7M | $2M | $1M | $895.0K | $906.0K | $287.0K | · | · | |
| R&D Expense | $33M | $23M | $25M | · | · | · | · | · | · | · | |
| SG&A Expense | $116M | $113M | $106M | $112M | $92M | $77M | $75M | $70M | $38M | $21M | |
| Operating Expenses | $169M | $155M | $137M | $176M | $162M | $138M | $128M | $117M | $84M | $90M | |
| Operating Income | $125M | $24M | $-20M | $-56M | $-12M | $-29M | $-69M | $-73M | $-80M | $-70M | |
| Interest Expense | · | $8M | $7M | $4M | $5M | $1M | $335.0K | · | · | · | |
| Interest Income | $4M | $2M | $2M | $684.0K | $47.0K | $582.0K | $3M | $2M | $892.0K | $437.0K | |
| Pretax Income | $122M | $18M | $-25M | $-59M | $-17M | $-30M | $-67M | · | · | · | |
| Income Tax | $-245M | $881.0K | $0 | · | $605.0K | · | · | $0 | $0 | $0 | |
| Net Income | $367M | $17M | $-25M | $-59M | $-18M | $-30M | $-67M | $-70M | $-78M | $-69M | |
| EPS (Basic) | $20.40 | $0.99 | $-1.44 | $-3.44 | $-0.11 | $-0.18 | $-0.40 | · | · | · | |
| EPS (Diluted) | $19.48 | $0.99 | $-1.44 | $-3.44 | $-0.11 | $-0.18 | $-0.40 | · | · | · | |
| Shares (Basic) | 17,987,000 | 17,579,000 | 17,401,000 | 17,049,000 | 170,492,000 | 168,754,000 | 167,400,000 | · | · | · | |
| Shares (Diluted) | 18,840,000 | 17,687,000 | 17,401,000 | 17,049,000 | 170,492,000 | 168,754,000 | 167,400,000 | · | · | · | |
| EBITDA | $128M | $26M | $-19M | $-55M | $-11M | $-28M | $-68M | $-72M | · | $-69M |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $41M | $57M | $33M | $24M | $19M | $30M | $23M | $76M | $38M | $18M | |
| Short-term Investments | $114M | $21M | $24M | $34M | $106M | $27M | $76M | $52M | $77M | $57M | |
| Receivables | $52M | $42M | $31M | $40M | $15M | $16M | $10M | $4M | $0 | $0 | |
| Inventory | $12M | $6M | $6M | $9M | $7M | $2M | $1M | $894.0K | · | · | |
| Prepaid Expense | $22M | $10M | $6M | $8M | $7M | $14M | $9M | $3M | $2M | $1M | |
| Other Current Assets | $5M | $5M | · | · | · | · | · | · | · | · | |
| Current Assets | $240M | $135M | $99M | $116M | $154M | $89M | $119M | $137M | $117M | $76M | |
| PP&E (Net) | $30.0K | $92.0K | $165.0K | $857.0K | $2M | $3M | $2M | $1M | $875.0K | $1M | |
| PP&E (Gross) | $347.0K | $353.0K | $2M | $12M | $17M | $16M | $15M | $14M | $13M | $20M | |
| Accum. Depreciation | $317.0K | $261.0K | $2M | $11M | $15M | $14M | $13M | $13M | $12M | $19M | |
| Intangibles | $25M | $27M | $14M | $15M | · | · | · | · | · | · | |
| Other Non-current Assets | $2M | $2M | $3M | $640.0K | $974.0K | $824.0K | $696.0K | $735.0K | $803.0K | $764.0K | |
| Total Assets | $514M | $164M | $117M | $134M | $167M | $110M | $148M | $139M | $119M | $78M | |
| Accounts Payable | $7M | $3M | $7M | $23M | $4M | $4M | $4M | $6M | $3M | $6M | |
| Accrued Liabilities | · | · | · | · | $4M | $4M | $3M | · | · | · | |
| Current Liabilities | $99M | $63M | $53M | $65M | $64M | $41M | $58M | $28M | $18M | $23M | |
| Capital Leases | $395.0K | $0 | $285.0K | $972.0K | $759.0K | $11M | $19M | · | · | · | |
| Other Non-current Liabilities | $0 | $40M | $40M | $42M | $53M | $5M | $5M | · | $38.0K | $2.0K | |
| Total Liabilities | $122M | $161M | $146M | $148M | $137M | · | · | · | · | · | |
| Long-term Debt | $52M | $60M | $60M | $40M | $20M | $20M | $10M | · | · | · | |
| Common Stock | $18.0K | $18.0K | $17.0K | $174.0K | $172.0K | $169.0K | $168.0K | $167.0K | $147.0K | $100.0K | |
| Retained Earnings | $-1.02B | $-1.39B | $-1.41B | $-1.38B | $-1.32B | $-1.31B | $-1.28B | $-1.21B | $-1.14B | $-1.06B | |
| AOCI | $181.0K | $10.0K | $8.0K | $-153.0K | $-102.0K | $-4.0K | $23.0K | $-24.0K | $-82.0K | $-18.0K | |
| Stockholders' Equity | $391M | $3M | $-29M | $-14M | $30M | $34M | $54M | $110M | $101M | $55M | |
| Liabilities + Equity | $514M | $164M | $117M | $134M | $167M | $110M | $148M | $139M | $119M | $78M | |
| Shares Outstanding | 18,310,934 | 17,710,216 | 17,482,513 | 173,398,645 | 171,602,226 | 169,316,782 | 167,987,850 | 167,171,505 | 146,814,906 | 99,269,418 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $1M | $998.0K | $1M | $706.0K | $683.0K | $594.0K | $465.0K | $941.0K | |
| Stock-based Comp | $13M | $12M | $9M | $12M | $9M | $7M | $9M | $8M | $6M | $7M | |
| Deferred Tax | $-246M | $0 | $0 | · | · | · | · | · | · | · | |
| Amort. of Intangibles | $2M | $2M | $1M | $100.0K | · | · | · | · | · | · | |
| Restructuring | · | · | · | $1M | $4M | · | · | · | · | $6M | |
| Other Non-cash | $-61M | $-635.0K | $9M | $-29M | $13M | $-30M | $16M | $3M | · | · | |
| Operating Cash Flow | $76M | $31M | $-6M | $-74M | $6M | $-52M | $-42M | $-59M | $-78M | $-76M | |
| CapEx | · | · | · | $450.0K | $627.0K | $1M | $1M | $1M | $164.0K | $804.0K | |
| Investing Cash Flow | $-92M | $4M | $-4M | $73M | $-80M | $47M | $-24M | $25M | $-19M | $25M | |
| Stock Issued | · | · | · | · | · | · | · | $67M | $114M | $24M | |
| Net Stock Activity | · | · | · | · | · | · | · | $67M | · | $30M | |
| Financing Cash Flow | $601.0K | $-12M | $18M | $7M | $63M | $13M | $11M | $72M | $118M | $25M | |
| Net Change in Cash | · | · | · | · | · | · | · | $38M | $21M | $-26M | |
| Taxes Paid | $1M | $331.0K | $81.0K | · | · | · | · | · | · | · | |
| Free Cash Flow | · | · | · | $-74M | $5M | $-53M | $-43M | $-60M | · | $-77M | |
| Levered FCF | · | · | · | · | $221.1K | · | · | · | · | · |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 42.6% | 13.5% | -17.5% | -46.2% | -8.4% | -26.7% | -116.5% | -163.3% | · | · | |
| Net Margin | 124.7% | 9.8% | -21.5% | -48.7% | -12.0% | -27.4% | -112.8% | -158.3% | · | · | |
| Pretax Margin | 41.4% | 10.2% | -21.5% | -48.7% | -11.6% | · | · | · | · | · | |
| EBITDA Margin | 43.5% | 14.7% | -16.5% | -45.4% | -7.6% | -26.0% | -115.4% | -162.0% | · | · | |
| ROA | 108.3% | 12.4% | -20.0% | -38.8% | -12.9% | -23.1% | -46.7% | -54.6% | · | · | |
| ROE | 155.1% | -308.2% | 83.0% | 350.2% | -44.8% | -70.0% | -109.0% | -66.1% | · | · | |
| ROIC | 96.5% | 700.5% | · | · | -42.6% | · | · | · | · | · |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.4 | 2.1 | 1.9 | 1.8 | 2.4 | 2.2 | 2.0 | 4.9 | · | 3.4 | |
| Quick Ratio | 2.1 | 1.9 | 1.6 | 1.5 | 2.2 | 1.8 | 1.9 | 4.8 | · | 3.3 | |
| Interest Coverage | · | 3.1 | -3.0 | -15.0 | -2.6 | -21.4 | -206.2 | · | · | · |
Efficienza
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.9 | 1.3 | 0.9 | 0.8 | 1.1 | 0.8 | 0.4 | 0.3 | · | · | |
| Inventory Turnover | 2.2 | 3.2 | 1.0 | 0.2 | 0.3 | 0.6 | 0.8 | 0.6 | · | · | |
| Receivables Turnover | 6.3 | 5.0 | 3.3 | 4.3 | 9.5 | 8.3 | 8.4 | 21.8 | · | · |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $21.38 | $0.19 | $-0.16 | $-0.08 | $0.18 | $0.20 | $0.32 | $0.66 | · | $0.55 | |
| Revenue / Share | $15.62 | $10.14 | $0.67 | $0.70 | $0.88 | · | · | · | · | · | |
| Cash Flow / Share | $4.02 | $1.78 | $-0.03 | $-0.43 | $0.03 | · | · | · | · | · | |
| Cash / Share | $2.22 | $3.20 | $0.19 | $0.14 | $0.11 | $0.18 | $0.13 | $0.46 | · | $0.18 | |
| EPS (TTM) | $19.48 | $0.99 | $-1.44 | $-3.44 | $-0.11 | $-0.18 | $-0.40 | · | · | · |
Tassi di Crescita
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 64.1% | 53.4% | -2.8% | -19.4% | 37.4% | · | · | · | · | · | |
| Revenue CAGR 3Y | 34.8% | 6.3% | 2.5% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 22.1% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 1867.7% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 1999.1% | · | · | · | · | · | · | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $294M | $179M | $117M | $120M | $149M | $109M | $59M | $45M | $4M | $20M | |
| Net Income TTM | $367M | $17M | $-25M | $-59M | $-18M | $-30M | $-67M | $-70M | $-78M | $-69M | |
| Market Cap | $784M | $298M | $2.53B | $2.60B | $4.55B | $5.93B | $3.59B | $3.84B | · | $2.36B | |
| P/E | 2.2 | 17.0 | -10.1 | -4.4 | -240.9 | -194.4 | -53.5 | · | · | · | |
| P/S | 2.7 | 1.7 | 21.7 | 21.6 | 30.5 | 54.6 | 60.6 | 86.4 | · | 115.9 | |
| P/B | 2.0 | 90.6 | -88.5 | -191.0 | 149.7 | 174.2 | 66.8 | 35.0 | · | 42.9 | |
| P / Tangible Book | 2.1 | · | · | · | 149.7 | 174.2 | · | · | · | · | |
| P / Cash Flow | 10.4 | 9.5 | -441.4 | -35.3 | 773.6 | -113.6 | -86.6 | -65.4 | · | -31.1 | |
| P / FCF | · | · | · | -35.0 | 866.0 | -110.9 | -83.7 | -64.2 | · | -30.8 | |
| Earnings Yield | 45.5% | 5.9% | -9.9% | -22.9% | -0.42% | -0.51% | -1.9% | · | · | · |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $79M | $59M | $70M | $69M | $102M | $53M | $58M | $55M | $37M | $30M | $28M | $27M | $26M | $22M | $30M | $17M | |
| Cost of Revenue | $9M | $5M | $6M | $5M | $5M | $4M | $6M | $8M | $3M | $2M | $1M | $1M | $977.0K | $250.0K | $1M | $121.0K | |
| R&D Expense | $14M | $12M | · | · | $7M | $8M | · | · | · | · | · | · | · | · | · | · | |
| SG&A Expense | $33M | $31M | $30M | $29M | $29M | $28M | $30M | $27M | $28M | $28M | $25M | $26M | $28M | $26M | $27M | $27M | |
| Operating Expenses | $55M | $47M | $47M | $41M | $41M | $41M | $41M | $41M | $36M | $36M | $33M | $32M | $39M | $41M | $43M | $43M | |
| Operating Income | $24M | $12M | $23M | $28M | $61M | $13M | $17M | $14M | $447.0K | $-7M | $-4M | $-5M | $-13M | $-18M | $-13M | $-26M | |
| Interest Expense | · | · | · | $2M | $2M | $2M | · | $2M | $2M | $2M | $2M | $2M | $1M | $826.0K | $569.0K | $1M | |
| Interest Income | $789.0K | $1M | $1M | $1M | $753.0K | $591.0K | $522.0K | $425.0K | $552.0K | $593.0K | $672.0K | $529.0K | $393.0K | $192.0K | $42.0K | $21.0K | |
| Pretax Income | $24M | $12M | $23M | $28M | $60M | $12M | $15M | $12M | $-1M | $-8M | · | · | · | $-19M | $-13M | $-27M | |
| Income Tax | $6M | $3M | $-245M | $-280.0K | $369.0K | $65.0K | $881.0K | $0 | $0 | $0 | · | · | · | $0 | $0 | $0 | |
| Net Income | $17M | $9M | $268M | $28M | $60M | $11M | $14M | $12M | $-1M | $-8M | $-6M | $-7M | $-14M | $-19M | $-13M | $-27M | |
| EPS (Basic) | $0.93 | $0.47 | $14.88 | $1.55 | $3.33 | $0.64 | $0.81 | $0.71 | $-0.06 | $-0.47 | $-0.33 | $-0.38 | $-0.08 | $-0.11 | $-0.08 | $-0.16 | |
| EPS (Diluted) | $0.88 | $0.44 | $14.11 | $1.46 | $3.28 | $0.63 | $0.82 | $0.70 | $-0.06 | $-0.47 | $-0.33 | $-0.38 | $-0.08 | $-0.11 | $-0.08 | $-0.16 | |
| Shares (Basic) | 18,541,000 | 18,412,000 | · | 18,038,000 | 17,885,000 | 17,808,000 | · | 17,600,000 | 17,549,000 | 17,520,000 | 17,436,000 | 17,356,000 | 173,568,000 | 172,836,000 | 172,147,000 | 171,774,000 | |
| Shares (Diluted) | 19,570,000 | 19,686,000 | · | 19,156,000 | 18,162,000 | 18,169,000 | · | 17,648,000 | 17,549,000 | 17,520,000 | 17,436,000 | 17,356,000 | 173,568,000 | 172,836,000 | 172,147,000 | 171,774,000 | |
| EBITDA | $24M | $12M | · | $28M | $61M | $13M | · | $14M | $447.0K | $-7M | $-4M | $-5M | $-12M | $-18M | $-13M | $-26M |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $61M | $24M | $41M | $49M | $53M | $46M | $57M | $52M | $36M | $26M | $45M | $49M | $40M | $30M | $27M | $25M | |
| Short-term Investments | $35M | $122M | $114M | $89M | $55M | $31M | $21M | $9M | $13M | $24M | $17M | $16M | $18M | $52M | $62M | $83M | |
| Receivables | $56M | $50M | $52M | $46M | $40M | $42M | $42M | $31M | $29M | $28M | $24M | $21M | $29M | $16M | $17M | $15M | |
| Inventory | $14M | $12M | $12M | $13M | $10M | $5M | $6M | $5M | $8M | $7M | $6M | $11M | $11M | $7M | $6M | $7M | |
| Prepaid Expense | $20M | $26M | $22M | $19M | $17M | $23M | $10M | $10M | $9M | $9M | $3M | $5M | $8M | $6M | $8M | $9M | |
| Other Current Assets | $5M | $7M | $5M | $6M | $5M | $6M | $5M | · | · | · | · | · | · | · | · | · | |
| Current Assets | $186M | $234M | $240M | $215M | $175M | $147M | $135M | $106M | $95M | $92M | $95M | $101M | $107M | $110M | $121M | $139M | |
| PP&E (Net) | · | · | $30.0K | $54.0K | $57.0K | $76.0K | $92.0K | $99.0K | $115.0K | $140.0K | $190.0K | $215.0K | $294.0K | $2M | $2M | $2M | |
| PP&E (Gross) | · | · | $347.0K | · | · | · | $353.0K | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $317.0K | · | · | · | $261.0K | · | · | · | · | · | · | · | · | · | |
| Intangibles | $94M | $24M | $25M | $25M | $26M | $27M | $27M | $28M | $28M | $29M | · | · | · | · | · | · | |
| Other Non-current Assets | $3M | $2M | $2M | $1M | $4M | $2M | $2M | $5M | $5M | $4M | $5M | $541.0K | $542.0K | $484.0K | $403.0K | $464.0K | |
| Total Assets | $521M | $505M | $514M | $243M | $207M | $176M | $164M | $139M | $128M | $127M | $115M | $117M | $124M | $116M | $128M | $149M | |
| Accounts Payable | $4M | $4M | $7M | $4M | $7M | $4M | $3M | $4M | $6M | $9M | $8M | $5M | $6M | $3M | $2M | $5M | |
| Current Liabilities | $96M | $89M | $99M | $94M | $87M | $67M | $63M | $54M | $59M | $73M | $48M | $44M | $46M | $47M | $55M | $59M | |
| Capital Leases | $58.0K | $228.0K | $395.0K | $556.0K | $714.0K | $864.0K | $0 | · | · | $100.0K | $466.0K | $628.0K | $802.0K | · | · | · | |
| Other Non-current Liabilities | · | · | $0 | · | · | $40M | $40M | $40M | $40M | $40M | $39M | $41M | $42M | $49M | $47M | $53M | |
| Total Liabilities | $96M | $105M | $122M | $125M | $125M | $157M | $161M | $154M | $158M | $158M | $147M | $145M | $148M | · | · | · | |
| Long-term Debt | · | $45M | $52M | $60M | $60M | $60M | · | $60M | $60M | $60M | $60M | $60M | $60M | $40M | $30M | $30M | |
| Common Stock | $18.0K | $18.0K | $18.0K | $18.0K | $18.0K | $18.0K | $18.0K | $17.0K | $17.0K | $175.0K | $175.0K | $175.0K | $174.0K | $173.0K | $173.0K | $172.0K | |
| Retained Earnings | $-997M | $-1.01B | $-1.02B | $-1.29B | $-1.32B | $-1.38B | $-1.39B | $-1.40B | $-1.42B | $-1.42B | $-1.41B | $-1.40B | $-1.40B | $-1.38B | $-1.36B | $-1.35B | |
| AOCI | $-148.0K | $-128.0K | $181.0K | $96.0K | $6.0K | $-2.0K | $10.0K | $11.0K | $-9.0K | $-5.0K | $-15.0K | $-25.0K | $-27.0K | $-286.0K | $-438.0K | $-416.0K | |
| Stockholders' Equity | $425M | $400M | $391M | $118M | $82M | $19M | $3M | $-15M | $-30M | $-32M | $-32M | $-28M | $-24M | $-20M | $-4M | $7M | |
| Liabilities + Equity | $521M | $505M | $514M | $243M | $207M | $176M | $164M | $139M | $128M | $127M | $115M | $117M | $124M | $116M | $128M | $149M | |
| Shares Outstanding | · | · | 18,310,934 | · | · | · | 17,710,216 | · | · | · | · | · | · | · | · | · |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $848.0K | $597.0K | $601.0K | $603.0K | $607.0K | $604.0K | $604.0K | $611.0K | $613.0K | $400.0K | $292.0K | $296.0K | $357.0K | $240.0K | $237.0K | $237.0K | |
| Stock-based Comp | $7M | $3M | $3M | $3M | $3M | $3M | $2M | $3M | $3M | $5M | $2M | $2M | $3M | $3M | $2M | $3M | |
| Amort. of Intangibles | · | $600.0K | $600.0K | $600.0K | $600.0K | $600.0K | $500.0K | $600.0K | $600.0K | $400.0K | $300.0K | $300.0K | $300.0K | · | · | · | |
| Other Non-cash | · | $-10M | · | · | · | $-16M | · | · | · | $-2M | · | · | $6M | · | · | $-2M | |
| Operating Cash Flow | $31M | $3M | $22M | $24M | $31M | $-893.0K | $15M | $22M | $302.0K | $-5M | $-1M | $6M | $-4M | $-13M | $-13M | $-26M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | · | · | $189.0K | $-36.0K | $224.0K | |
| Investing Cash Flow | $17M | $-8M | $-25M | $-33M | $-23M | $-11M | $-11M | $4M | $11M | $313.0K | $-1M | $3M | $777.0K | $10M | $21M | $23M | |
| Stock Repurchased | $511.0K | $4M | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $-4M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-12M | $-11M | $-5M | $4M | $418.0K | $484.0K | $1M | $-10M | $-752.0K | $-3M | $-869.0K | $-373.0K | $19M | $6M | $-6M | $9M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-26M | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-27M |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 29.9% | 20.2% | · | 40.9% | 60.1% | 23.9% | · | 25.4% | 1.2% | -23.6% | -15.9% | -19.6% | -48.8% | -82.1% | -43.5% | -156.9% | |
| Net Margin | 22.0% | 14.7% | · | 40.2% | 58.6% | 21.5% | · | 22.5% | -2.8% | -27.9% | -20.2% | -24.6% | -51.9% | -85.0% | -45.2% | -164.0% | |
| Pretax Margin | 30.0% | 19.8% | · | 39.8% | 59.0% | 21.6% | · | · | · | · | · | · | · | -85.0% | -45.2% | -164.0% | |
| EBITDA Margin | 29.9% | 21.2% | · | 40.9% | 60.1% | 25.1% | · | 25.4% | 1.2% | -22.2% | -15.9% | -19.6% | -47.4% | -82.1% | -43.5% | -155.5% | |
| ROA | 4.8% | 2.5% | · | 14.6% | 35.6% | 7.6% | · | 9.8% | -0.84% | -6.6% | -4.9% | -5.4% | -9.9% | -12.6% | -8.2% | -15.0% | |
| ROE | 6.8% | 4.1% | · | 54.2% | 229.2% | -174.7% | · | -53.5% | 3.5% | 29.5% | 22.0% | 41.5% | 155.1% | -127.6% | -41.9% | -64.5% | |
| ROIC | 4.1% | 2.2% | · | 24.4% | 74.1% | 68.4% | · | · | · | · | · | · | · | 92.8% | 352.6% | -386.3% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | 2.6 | · | 2.3 | 2.0 | 2.2 | · | 2.0 | 1.6 | 1.3 | 2.0 | 2.3 | 2.4 | 2.3 | 2.2 | 2.3 | |
| Quick Ratio | 1.6 | 2.2 | · | 1.9 | 1.7 | 1.8 | · | 1.7 | 1.3 | 1.1 | 1.8 | 1.9 | 1.9 | 2.1 | 1.9 | 2.1 | |
| Interest Coverage | · | · | · | 15.0 | 32.6 | 6.9 | · | 6.8 | 0.2 | -3.7 | -2.4 | -2.8 | -10.6 | -22.3 | -22.8 | -21.8 |
Efficienza
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.4 | 0.6 | 0.4 | · | 0.4 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.2 | 0.1 | |
| Inventory Turnover | 0.7 | 0.6 | · | 0.5 | 0.5 | 0.8 | · | 1.5 | 0.3 | 0.2 | 0.2 | 0.1 | 0.1 | 0.0 | 0.2 | 0.0 | |
| Receivables Turnover | 1.6 | 1.3 | · | 1.8 | 3.0 | 1.5 | · | 2.0 | 1.5 | 1.0 | 1.4 | 1.4 | 1.2 | 1.5 | 1.7 | 0.2 |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $4.02 | $2.99 | · | $3.63 | $5.60 | $2.94 | · | $3.13 | $2.10 | $0.17 | $0.16 | $0.15 | $0.15 | $0.13 | $0.17 | $0.10 | |
| Cash Flow / Share | · | $0.14 | · | · | · | $-0.05 | · | · | · | $-0.03 | · | · | $-0.02 | · | · | $-0.15 | |
| EPS (TTM) | $16.89 | $19.29 | · | $6.19 | $5.43 | $2.09 | · | $-0.48 | $-1.51 | $-1.83 | $-3.88 | $-3.66 | $-3.36 | $-0.48 | $-0.49 | $-0.49 |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $277M | $300M | · | $282M | $268M | $203M | · | $157M | $130M | $120M | $132M | $127M | $130M | $89M | $89M | $85M | |
| Net Income TTM | $322M | $364M | · | $113M | $98M | $37M | · | $4M | $-14M | $-20M | $-24M | $-38M | $-45M | $-83M | $-85M | $-85M | |
| P/E | 2.3 | 1.4 | · | 4.6 | 3.4 | 8.6 | · | -33.7 | -5.4 | -8.1 | -2.8 | -3.5 | -3.9 | -24.6 | -23.1 | -61.0 | |
| Earnings Yield | 43.2% | 71.3% | · | 21.9% | 29.0% | 11.6% | · | -3.0% | -18.4% | -12.4% | -35.9% | -28.4% | -25.4% | -4.1% | -4.3% | -1.6% |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ricavi | $294M | $179M | $117M | $120M | $149M |
| Margine Operativo % | 42.6% | 13.5% | -17.5% | -46.2% | -8.4% |
| Utile netto | $367M | $17M | $-25M | $-59M | $-18M |
| EPS Diluito | $19.48 | $0.99 | $-1.44 | $-3.44 | $-0.11 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rapporto corrente | 2.4 | 2.1 | 1.9 | 1.8 | 2.4 |
| Quick Ratio | 2.1 | 1.9 | 1.6 | 1.5 | 2.2 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flusso di cassa libero | · | · | · | $-74M | $5M |
Proprietari istituzionali (13F) 169 filer · $637.8M totale · Aggiornato al 30 Settembre 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
169
Valore detenuto
$637.8M
Nuove posizioni
31
Posizioni chiuse
23
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 31 (+13 vs trimestre precedente) | 23 (-21 vs trimestre precedente) | 53 (-15 vs trimestre precedente) | 57 (+9 vs trimestre precedente) | +269K |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| BlackRock, Inc. | $75.885.690 | 1.939.818 | 11,90% | Azioni |
| Soleus Capital Management, L.P. | $72.117.876 | 1.843.504 | 11,31% | Azioni |
| ARMISTICE CAPITAL, LLC | $65.408.640 | 1.672.000 | 10,26% | Azioni |
| VANGUARD GROUP INC | $44.475.015 | 1.038.408 | 6,97% | Azioni |
| STATE STREET CORP | $40.684.565 | 1.039.994 | 6,38% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $30.713.386 | 785.107 | 4,82% | Azioni |
| AMERICAN CENTURY COMPANIES INC | $29.016.008 | 741.718 | 4,55% | Azioni |
| D. E. Shaw & Co., Inc. | $21.224.126 | 542.539 | 3,33% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $18.906.353 | 483.175 | 2,96% | Azioni |
| MARSHALL WACE, LLP | $14.372.414 | 367.393 | 2,25% | Azioni |
| CM Management, LLC | $9.780.000 | 250.000 | 1,53% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $9.143.439 | 233.728 | 1,43% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $8.917.295 | 227.951 | 1,40% | Azioni |
| GOLDMAN SACHS GROUP INC | $8.871.634 | 226.780 | 1,39% | Azioni |
| TWO SIGMA INVESTMENTS, LP | $8.120.451 | 207.578 | 1,27% | Azioni |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $7.628.000 | 195.000 | 1,20% | Azioni |
| MORGAN STANLEY | $7.278.237 | 186.049 | 1,14% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $6.049.008 | 154.627 | 0,95% | Azioni |
| NORTHERN TRUST CORP | $5.726.425 | 146.381 | 0,90% | Azioni |
| RENAISSANCE TECHNOLOGIES LLC | $5.705.496 | 145.846 | 0,89% | Azioni |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $5.131.644 | 131.177 | 0,80% | Azioni |
| AQR CAPITAL MANAGEMENT LLC | $4.882.214 | 124.801 | 0,77% | Azioni |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $4.858.078 | 124.184 | 0,76% | Azioni |
| Nuveen, LLC | $4.849.354 | 123.961 | 0,76% | Azioni |
| BANK OF AMERICA CORP /DE/ | $4.831.556 | 123.506 | 0,76% | Azioni |
| FRANKLIN RESOURCES INC | $4.825.999 | 123.364 | 0,76% | Azioni |
| UBS Group AG | $4.809.960 | 122.954 | 0,75% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $4.762.195 | 121.733 | 0,75% | Azioni |
| GLOBEFLEX CAPITAL L P | $4.407.729 | 112.672 | 0,69% | Azioni |
| CenterBook Partners LP | $4.286.574 | 109.575 | 0,67% | Azioni |
| Bank of New York Mellon Corp | $4.233.132 | 108.209 | 0,66% | Azioni |
| FMR LLC | $3.759.903 | 96.112 | 0,59% | Azioni |
| RITHOLTZ WEALTH MANAGEMENT | $3.694.884 | 94.450 | 0,58% | Azioni |
| JANUS HENDERSON GROUP PLC | $3.674.114 | 135.877 | 0,58% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $3.665.114 | 93.689 | 0,57% | Azioni |
| FIRST TRUST ADVISORS LP | $3.182.099 | 81.342 | 0,50% | Azioni |
| Empowered Funds, LLC | $3.097.678 | 79.184 | 0,49% | Azioni |
| Brandywine Global Investment Management, LLC | $3.065.343 | 71.570 | 0,48% | Azioni |
| Russell Investments Group, Ltd. | $2.973.196 | 76.002 | 0,47% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2.687.544 | 68.700 | 0,42% | Opzione Call |
| Squarepoint Ops LLC | $2.607.661 | 66.658 | 0,41% | Azioni |
| BURNEY CO/ | $2.181.683 | 55.769 | 0,34% | Azioni |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $2.159.424 | 55.200 | 0,34% | Azioni |
| WELLS FARGO & COMPANY/MN | $2.131.727 | 54.492 | 0,33% | Azioni |
| PRINCIPAL FINANCIAL GROUP INC | $2.032.088 | 51.945 | 0,32% | Azioni |
| OMERS ADMINISTRATION Corp | $2.030.328 | 51.900 | 0,32% | Azioni |
| WELLINGTON MANAGEMENT GROUP LLP | $1.989.800 | 50.864 | 0,31% | Azioni |
| Woodline Partners LP | $1.956.000 | 50.000 | 0,31% | Azioni |
| Connor, Clark & Lunn Investment Management Ltd. | $1.920.636 | 49.096 | 0,30% | Azioni |
| SEGALL BRYANT & HAMILL, LLC | $1.794.747 | 45.878 | 0,28% | Azioni |
Attivisti e proprietari del 5%+ 5 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata | 27 Gennaio 2005 | · | Deposito iniziale | Investimento passivo | SEC |
| I.R.S.Identification Nos. of above persons (entities only). FRAZIER HEALTHCARE II, L.P., I.R.S.Identification Nos. of above persons (entities only). FHM II, L.L.C., I.R.S.Identification Nos. of above persons (entities only). FRAZIER HEALTHCARE IV, L.P., I.R.S.Identification Nos. of above persons (entities only). FRAZIER AFFILIATES IV, L.P.., I.R.S.Identification Nos. of above persons (entities only). FHM IV, L.P., I.R.S.Identification Nos. of above persons (entities only). FHM IV, L.L.C., I.R.S.Identification Nos. of above persons (entities only). FRAZIER MANAGEMENT, L.L.C., I.R.S.Identification Nos. of above persons (entities only). FRAZIER & COMPANY, INC., I.R.S.Identification Nos. of above persons (entities only). ALAN D. FRAZIER | 14 Aprile 2004 | · | Deposito iniziale | Investimento passivo | SEC |
| Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata | 07 Luglio 2003 | · | Deposito iniziale | Campagna per il consiglio di amministrazione | SEC |
| MPM BioVentures III, L.P., MPM BioVentures III-QP, L.P., MPM BioVentures III Parallel Fund, L.P., MPM BioVentures III GmbH & Co. Beteiligungs KG, MPM Asset Management Investors 2003 BVIII, LLC, MPM BioEquities Master Fund, L.P., MPM BioVentures III GP, LP, MPM BioVentures III LLC, MPM BioEquities GP, LP, MPM BioEquities GP, LLC, Luke Evnin, Ansbert Gadicke, Nicholas Galakatos, Dennis Henner, Robert Liptak, Nick Simon, III, Michael Steinmetz, Kurt von Emster, Kurt Wheeler | 07 Luglio 2003 | · | Deposito iniziale | Campagna per il consiglio di amministrazione | SEC |
| MPM Bio Ventures III, L.P., MPM Bio Ventures III-QP, L.P., MPM Bio Ventures III Parallel Fund, L.P., MPM Bio Ventures III GmbH & Co. Beteiligungs KG, MPM Asset Management Investors 2003 BVIII, LLC, MPM BioEquities Master Fund, L.P., MPM Bio Ventures III GP, L.P., MPM Bio Ventures III LLC, MPM BioEquities GP, L.P., MPM BioEquities GP, LLC, Luke Evnin, Ansbert Gadicke, Nicholas Galakatos, Dennis Henner, Robert Liptak, Nicholas Simon, III, Michael Steinmetz, Kurt von Emster, Kurt Wheeler | 14 Maggio 2003 | · | Deposito iniziale | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 41 insider · 20 dirigenti · 20 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Raul R Rodriguez | CEO, President | 01 Settembre 2026 F | 273.362 | 0 | 0 | $0 |
| James M Gower | CEO & Board Chairman | 27 Febbraio 2014 A | 180.676 | 0 | 0 | $0 |
| Dean L Schorno | EVP & Chief Financial Officer | 02 Settembre 2026 M | 82.962 | 0 | 0 | $0 |
| Ryan D Maynard | EVP & CFO | 03 Novembre 2017 M | 0 | 0 | 0 | $0 |
| James H Welch | CFO, VP & Secretary | 25 Gennaio 2006 A | 3.757 | 0 | 0 | $0 |
| David A Santos | EVP, Chief Commercial Officer | 01 Settembre 2026 F | 61.622 | 0 | 0 | $0 |
| Raymond J. Furey | EVP, GC, CCO & Corp Sec | 01 Settembre 2026 F | 50.559 | 0 | 0 | $0 |
| Alison L. Hannah | EVP, Chief Medical Officer | 08 Luglio 2026 A | 35.025 | 0 | 0 | $0 |
| Lisa Rojkjaer | EVP, Chief Medical Officer | 17 Giugno 2026 A | 34.003 | 0 | 0 | $0 |
| Wolfgang Dummer | EVP & CMO | 02 Febbraio 2023 S | 72.459 | 0 | 0 | $0 |
| Dolly Vance | EVP Corp. Affairs, G.C., Sect. | 14 Settembre 2022 A | 60.260 | 0 | 0 | $0 |
| Nelson Cabatuan | VP,Finance & Princ.Acctg. Off. | 14 Maggio 2020 A | 58 | 0 | 0 | $0 |
| Eldon C. Mayer III | EVP & Chief Commercial Officer | 18 Novembre 2019 A | 215.000 | 0 | 0 | $0 |
| Joseph Lasaga | Sr.VP Bus.Dev.Alliance Mgmt. | 18 Novembre 2019 A | · | 0 | 0 | $0 |
| Esteban Masuda | Sr. VP Research | 18 Novembre 2019 S | · | 0 | 0 | $0 |
| Stacy Markel | EVP Human Resources | 20 Marzo 2019 A | · | 0 | 0 | $0 |
| Anne-Marie Duliege | EVP & Chief Medical Officer | 20 Marzo 2019 A | 0 | 0 | 0 | $0 |
| Donald G Payan | EVP, Pres. Discovery&Research | 30 Agosto 2016 S | 53.031 | 0 | 0 | $0 |
| Elliot B Grossbard | EVP, CMO | 26 Gennaio 2016 A | 2.000 | 0 | 0 | $0 |
| Robin D G Cooper | Sr. V.P. Pharmaceutical Scs. | 31 Gennaio 2008 A | 9.000 | 0 | 0 | $0 |
| Kamil Ali-Jackson | Direttore | 22 Giugno 2026 S | 10.125 | 0 | 2 | $-160.425 |
| Mark W Frohlich | Direttore | 15 Maggio 2026 A | 7.000 | 0 | 0 | $0 |
| Jane Wasman | Direttore | 15 Maggio 2026 A | 18.250 | 0 | 0 | $0 |
| Anthony Gregg Lapointe | Direttore | 15 Maggio 2026 A | 18.250 | 0 | 0 | $0 |
| MILLER MICHAEL PATRICK | Direttore | 15 Maggio 2026 A | 5.937 | 0 | 0 | $0 |
| Walter H Moos | Direttore | 15 Maggio 2026 A | 18.472 | 0 | 1 | $-145.440 |
| Brian L. Kotzin | Direttore | 25 Maggio 2024 A | 100.000 | 0 | 0 | $0 |
| LYONS GARY A | Direttore | 26 Maggio 2023 A | 75.000 | 0 | 0 | $0 |
| Keith Katkin | Direttore | 19 Maggio 2021 A | 25.000 | 0 | 0 | $0 |
| Bradford S Goodwin | Direttore | 19 Maggio 2021 A | 35.000 | 0 | 0 | $0 |
| Peter S Ringrose | Direttore | 17 Maggio 2018 A | · | 0 | 0 | $0 |
| SHERWIN STEPHEN A | Direttore | 11 Maggio 2016 A | · | 0 | 0 | $0 |
| Hollings Renton | Direttore | 15 Maggio 2013 A | · | 0 | 0 | $0 |
| Jean Deleage | Direttore | 28 Maggio 2010 A | 697 | 0 | 0 | $0 |
| Alan D Frazier | Direttore | 07 Agosto 2006 A | 10.905 | 0 | 0 | $0 |
| Nicholas J Simon III | Direttore | 03 Giugno 2005 A | 0 | 0 | 0 | $0 |
| Dennis Henner | Direttore | 05 Gennaio 2005 S | 0 | 0 | 0 | $0 |
| Michael Steinmetz | Proprietario del 10% | 02 Agosto 2004 S | 1.833.597 | 0 | 0 | $0 |
| Nicholas Galakatos | Proprietario del 10% | 02 Luglio 2004 S | 1.833.597 | 0 | 0 | $0 |
| Luke Evnin | Proprietario del 10% | 02 Luglio 2004 S | 1.833.597 | 0 | 0 | $0 |
| ANSBERT GADICKE | Proprietario del 10% | 02 Luglio 2004 J | 0 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 31 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| BBP · ETFis Series Trust I | 1,54% | 41.313 NS | 31 Luglio 2026 | N-PORT |
| IDNA · iShares Trust | 0,82% | 44.383 SH | 11 Settembre 2026 | Giornaliero |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,54% | 2.596 SH | 01 Ottobre 2026 | Giornaliero |
| IWC · iShares Trust | 0,21% | 62.481 SH | 11 Settembre 2026 | Giornaliero |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,18% | 29.124 NS | 31 Luglio 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,16% | 22.093 NS | 31 Luglio 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0,13% | 23.978 SH | 19 Agosto 2026 | Giornaliero |
| CALF · Pacer Funds Trust | 0,09% | 84.790 NS | 31 Luglio 2026 | N-PORT |
| IBB · iShares Trust | 0,06% | 136.671 SH | 11 Settembre 2026 | Giornaliero |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,06% | 1.309 SH | 01 Ottobre 2026 | Giornaliero |
| VFMO · VANGUARD WELLINGTON FUND | 0,05% | 27.549 SH | 19 Agosto 2026 | Giornaliero |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,05% | 15.998 SH | 19 Agosto 2026 | Giornaliero |
| PWS · Pacer Funds Trust | 0,05% | 302 NS | 31 Luglio 2026 | N-PORT |
| IWM · iShares Trust | 0,03% | 473.179 SH | 11 Settembre 2026 | Giornaliero |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 12.648 SH | 01 Ottobre 2026 | Giornaliero |
| RSSL · Global X Funds | 0,02% | 8.801 NS | 31 Luglio 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 105.855 SH | 19 Agosto 2026 | Giornaliero |
| TECB · iShares Trust | 0,02% | 1.868 SH | 11 Settembre 2026 | Giornaliero |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,01% | 619 SH | 01 Ottobre 2026 | Giornaliero |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 212.359 SH | 19 Agosto 2026 | Giornaliero |
| VHT · VANGUARD WORLD FUND | 0,01% | 54.159 SH | 19 Agosto 2026 | Giornaliero |
| DFAS · Dimensional ETF Trust | 0,01% | 32.659 NS | 31 Luglio 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 6.553 SH | 09 Settembre 2026 | Giornaliero |
| DFAC · Dimensional ETF Trust | 0,00% | 16.178 NS | 31 Luglio 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 22.835 SH | 11 Settembre 2026 | Giornaliero |
| DFAU · Dimensional ETF Trust | 0,00% | 3.010 NS | 31 Luglio 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 699 NS | 31 Luglio 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 555.846 SH | 19 Agosto 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1.629 SH | 19 Agosto 2026 | Giornaliero |
| DFUV · Dimensional ETF Trust | 0,00% | 112 NS | 31 Luglio 2026 | N-PORT |
| IWN · iShares Trust | · | 171.420 SH | 11 Settembre 2026 | Giornaliero |
RIGL Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 11 analisti
COMPRA
Target mediano
$55.00
+16,6%
4 36,4%
Acquisto forte
4 36,4%
Compra
3 27,3%
Mantieni
0 0,0%
Vendi
0 0,0%
Vendita forte
Target Price a 12 Mesi
5 analisti · 2026-09-28Target medio $63.00 +33,6%
Ora
Prezzo attuale $47.15
Basso$43.00
Media$63.00
Alto$85.00
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| RIGL | $784M | 2.2 | 64.1% | 124.7% | 155.1% | · |
| KURA | $913M | -3.3 | 25.2% | -413.0% | -116.2% | · |
| CRVS | $575M | -14.5 | · | · | -21.6% | · |
| GLUE | $1.03B | · | 63.5% | -31.2% | -15.4% | · |
| JBIO | $761M | -4.8 | · | · | -47.7% | · |
| SANA | $1.09B | -4.2 | · | · | -172.3% | · |
| OBX | · | · | · | · | · | · |
| ARDX | $1.42B | -22.4 | 22.1% | -15.1% | -40.2% | · |
| AVTX | $336M | -3.1 | -86.6% | -132642.4% | -83.4% | · |
Ultime notizie Notizie recenti che menzionano questa società
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-Q depositato Ago 4, 2026